What are the potential interactions between Adderall (amphetamine and dextroamphetamine) and bupropion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Potential Interactions Between Adderall and Bupropion

Caution is advised when combining Adderall (amphetamine and dextroamphetamine) with bupropion due to potential pharmacokinetic interactions that may increase the risk of adverse effects, including seizures, elevated blood pressure, and neuropsychiatric symptoms. 1

Pharmacological Mechanism of Interaction

  • Both medications affect similar neurotransmitter systems, primarily dopamine and norepinephrine, which can lead to additive stimulant effects when used together 1
  • Bupropion and its metabolites inhibit cytochrome P450 2D6 (CYP2D6), which may interfere with the metabolism of amphetamines, potentially increasing their plasma concentrations and effects 2

Potential Adverse Effects

Neuropsychiatric Effects

  • Increased risk of neuropsychiatric symptoms including:
    • Anxiety, agitation, and insomnia 1
    • Potential for delirium, particularly in elderly patients or those with other risk factors 2
    • Possible increased risk of seizures, especially in patients with predisposing factors 1

Cardiovascular Effects

  • Potential for additive effects on blood pressure and heart rate 1
  • Both medications independently can cause cardiovascular stimulation, and the combination may enhance these effects 1

Laboratory Testing Considerations

  • Bupropion can cause false positive results for amphetamines on urine drug screens using certain immunoassays (particularly Syva EMIT II) 3
  • This could lead to misinterpretation of drug testing results in clinical or occupational settings 3

Clinical Management Recommendations

Before Initiating Combination Therapy

  • Assess for contraindications to either medication:
    • History of seizures or seizure disorders 1
    • Eating disorders 1
    • Uncontrolled hypertension 1
    • Closed-angle glaucoma 1

During Combined Treatment

  • Monitor vital signs regularly, particularly blood pressure and heart rate 1
  • Start with lower doses of both medications when used concomitantly 1
  • Consider intermittent use of stimulants rather than continuous daily dosing when possible 1
  • Monitor for signs of increased stimulant effects or toxicity, including:
    • Insomnia or sleep disturbances 1
    • Excessive anxiety or agitation 1
    • Appetite suppression and weight loss 1

Special Populations

Pregnancy Considerations

  • Both medications cross the placenta and should be used with caution during pregnancy 1
  • If treatment is necessary during pregnancy, the lowest effective doses should be used 1
  • Consider risks of untreated ADHD versus medication exposure 1

Breastfeeding Considerations

  • Both medications can be present in breast milk 1
  • Limited data on bupropion in breastfeeding (21 cases) shows generally no adverse events, though there have been two case reports of seizures in breastfed infants 1
  • Monitor breastfed infants for irritability, poor feeding, and sleep disturbances when mothers are taking these medications 1

Research Evidence on Combination Use

  • There are no formal studies specifically examining the combination of bupropion and stimulants in the treatment of ADHD or other psychiatric conditions 1
  • Some research suggests that acute doses of both amphetamine and bupropion can increase cigarette smoking behavior, which may be relevant for patients using this combination who also smoke 4
  • Despite bupropion's structural similarity to amphetamines, studies in individuals with histories of substance abuse show that bupropion lacks significant amphetamine-like subjective effects 5, 6

Human Pharmacology Laboratories research indicates that bupropion does not produce the same euphoric or reinforcing effects as amphetamines, suggesting a lower abuse potential despite the pharmacological overlap 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Delirium associated with concomitant use of duloxetine and bupropion in an elderly patient.

Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2017

Research

Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2011

Research

Bupropion: clinical assay for amphetamine-like abuse potential.

The Journal of clinical psychiatry, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.